Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR.

Am J Psychiatry. 1996 Dec;153(12):1554-63.

PMID:
8942451
2.

Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.

Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, Barnett IS, Duyn JH, Frank JA, Rapoport JL, Weinberger DR.

Am J Psychiatry. 1998 Oct;155(10):1376-83.

PMID:
9766769
3.

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR.

Biol Psychiatry. 1998 May 1;43(9):641-8.

PMID:
9582997
4.

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging.

Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, Post R, Weinberger DR.

Biol Psychiatry. 2003 May 15;53(10):906-13.

PMID:
12742678
5.

Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia.

Bertolino A, Callicott JH, Nawroz S, Mattay VS, Duyn JH, Tedeschi G, Frank JA, Weinberger DR.

Neuropsychopharmacology. 1998 Jan;18(1):1-9.

6.

Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.

Callicott JH, Egan MF, Bertolino A, Mattay VS, Langheim FJ, Frank JA, Weinberger DR.

Biol Psychiatry. 1998 Nov 15;44(10):941-50. Erratum in: Biol Psychiatry 1999 Jan 15;45(2):following 244.

PMID:
9821558
7.

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.

Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K, Ron MA.

Schizophr Res. 2003 Nov 1;64(1):63-71.

PMID:
14511802
8.

Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.

Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.

Psychiatry Res. 2004 Jul 30;131(2):95-105.

PMID:
15313516
9.

N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.

Jakary A, Vinogradov S, Feiwell R, Deicken RF.

Schizophr Res. 2005 Jul 15;76(2-3):173-85. Epub 2005 Apr 15.

PMID:
15949650
10.

Proton magnetic resonance spectroscopy of the human brain in schizophrenia.

Deicken RF, Johnson C, Pegues M.

Rev Neurosci. 2000;11(2-3):147-58. Review.

PMID:
10718151
11.

[Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia].

Jia YB, Wang Y, Ling XY, Zhong SM, Huang L.

Nan Fang Yi Ke Da Xue Xue Bao. 2012 Mar;32(3):374-8. Chinese.

12.

Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma.

Coplan JD, Mathew SJ, Mao X, Smith EL, Hof PR, Coplan PM, Rosenblum LA, Gorman JM, Shungu DC.

Psychiatry Res. 2006 Jun 30;147(1):27-39. Epub 2006 Jun 22.

PMID:
16797939
13.

Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study.

Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR.

Cereb Cortex. 1997 Dec;7(8):740-8.

PMID:
9408038
14.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
15.

Proton MRS in twin pairs discordant for schizophrenia.

Lutkenhoff ES, van Erp TG, Thomas MA, Therman S, Manninen M, Huttunen MO, Kaprio J, Lönnqvist J, O'Neill J, Cannon TD.

Mol Psychiatry. 2010 Mar;15(3):308-18. doi: 10.1038/mp.2008.87. Epub 2008 Jul 22.

PMID:
18645571
16.

Hippocampal 1H MRS in first-episode bipolar I patients.

Atmaca M, Yildirim H, Ozdemir H, Poyraz AK, Tezcan E, Ogur E.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1235-9. Epub 2006 May 24.

PMID:
16725248
17.

1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.

O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR.

Neuroimage. 2004 Apr;21(4):1781-9.

18.

Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla.

Stern AJ, Savostyanova AA, Goldman A, Barnett AS, van der Veen JW, Callicott JH, Mattay VS, Weinberger DR, Marenco S.

Biol Psychiatry. 2008 Nov 15;64(10):856-62. doi: 10.1016/j.biopsych.2008.07.009. Epub 2008 Aug 15.

19.

Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.

Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.

Psychiatry Clin Neurosci. 2006 Jun;60(3):365-72.

20.

Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.

Fujimoto T, Nakano T, Takano T, Takeuchi K, Yamada K, Fukuzako T, Akimoto H.

Biol Psychiatry. 1996 Jul 1;40(1):14-8.

PMID:
8780850

Supplemental Content

Support Center